Lv1
26 积分 2022-05-17 加入
ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma
9天前
已完结
ABS0750 FIRST USE OF NOVEL BCMA AND CD19 NANOBODY-BASED COMPOUND CAR-T THERAPY TO TARGET B-CELLS AND PLASMA CELLS IN PRECLINICAL STUDY OF AUTOIMMUNE DISEASES
9天前
已关闭
An Immunologic Model for Rapid Vaccine Assessment — A Clinical Trial in a Test Tube
14天前
已完结
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
29天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
30天前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
1个月前
已完结
PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
1个月前
已完结
A novel tumor-bearing humanized mouse model for evaluating the efficacy and predictive safety of bispecific T cell engager
2个月前
已关闭
A novel tumor-bearing humanized mouse model for evaluating the efficacy and predictive safety of bispecific T cell engager
2个月前
已关闭
The impact of chemical reactivity on the quality and stability of RNA–LNP pharmaceuticals
2个月前
已完结
皖公网安备34019202002308
